E. Lebacq

467 total citations
13 papers, 351 citations indexed

About

E. Lebacq is a scholar working on Pharmacology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, E. Lebacq has authored 13 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Infectious Diseases and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in E. Lebacq's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Viral gastroenteritis research and epidemiology (2 papers) and Pharmacology and Obesity Treatment (2 papers). E. Lebacq is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Viral gastroenteritis research and epidemiology (2 papers) and Pharmacology and Obesity Treatment (2 papers). E. Lebacq collaborates with scholars based in Belgium, France and United States. E. Lebacq's co-authors include Lars Østergaard, Jan Poolman, Gudrun Maechler, Dominique Boutriau, Jiřı́ Beran, Christian Van Hoecke, Aino Karvonen, Fred Zepp, A. Delem and Merimaaria Espo and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Vaccine.

In The Last Decade

E. Lebacq

13 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Lebacq Belgium 9 174 103 80 78 77 13 351
Gabriele Buttinelli Italy 14 340 2.0× 141 1.4× 32 0.4× 23 0.3× 238 3.1× 30 494
Annalisa Grandin Italy 8 135 0.8× 102 1.0× 28 0.3× 14 0.2× 20 0.3× 17 257
Robert E. Levitz United States 10 113 0.6× 255 2.5× 71 0.9× 80 1.0× 12 0.2× 15 440
Monjori Mitra India 11 196 1.1× 126 1.2× 9 0.1× 110 1.4× 18 0.2× 53 431
I. Rebière France 8 64 0.4× 73 0.7× 13 0.2× 20 0.3× 10 0.1× 13 295
R.E. Tettmar United Kingdom 7 91 0.5× 151 1.5× 37 0.5× 15 0.2× 13 0.2× 11 346
Chang-Phone Fung Taiwan 7 167 1.0× 143 1.4× 23 0.3× 4 0.1× 75 1.0× 7 404
Joo-Shil Lee South Korea 11 189 1.1× 51 0.5× 3 0.0× 30 0.4× 21 0.3× 23 301
Birgitte Korsager Denmark 9 96 0.6× 93 0.9× 29 0.4× 6 0.1× 5 0.1× 22 288
P Joseph United States 10 155 0.9× 109 1.1× 64 0.8× 13 0.2× 11 0.1× 16 328

Countries citing papers authored by E. Lebacq

Since Specialization
Citations

This map shows the geographic impact of E. Lebacq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lebacq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lebacq more than expected).

Fields of papers citing papers by E. Lebacq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Lebacq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lebacq. The network helps show where E. Lebacq may publish in the future.

Co-authorship network of co-authors of E. Lebacq

This figure shows the co-authorship network connecting the top 25 collaborators of E. Lebacq. A scholar is included among the top collaborators of E. Lebacq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Lebacq. E. Lebacq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Østergaard, Lars, E. Lebacq, Jan Poolman, Gudrun Maechler, & Dominique Boutriau. (2008). Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years. Vaccine. 27(1). 161–168. 78 indexed citations
2.
Vesikari, Timo, Aino Karvonen, Tiina Korhonen, et al.. (2004). Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine. 22(21-22). 2836–2842. 112 indexed citations
3.
Stockis, Armel, et al.. (2002). Pharmacokinetic profile of a new controlled-release isosorbide-5-mononitrate 60 mg scored tablet (Monoket Multitab®). European Journal of Pharmaceutics and Biopharmaceutics. 53(1). 49–56. 12 indexed citations
4.
Lebacq, E.. (2001). Comparative Tolerability and Immunogenicity of Typherix??? or Typhim Vi??? in Healthy Adults*. BioDrugs. 15(Supplement 1). 5–12. 23 indexed citations
5.
Hoecke, Christian Van, E. Lebacq, Jiřı́ Beran, & Dennis Parenti. (1999). Alternative Vaccination Schedules (0, 1, and 6 Months Versus 0, 1, and 12 Months) for a Recombinant OspA Lyme Disease Vaccine. Clinical Infectious Diseases. 28(6). 1260–1264. 35 indexed citations
6.
Hoecke, Christian Van, et al.. (1998). Concomitant Vaccination against Hepatitis A and Typhoid Fever. Journal of Travel Medicine. 5(3). 116–120. 25 indexed citations
7.
Stockis, Armel, et al.. (1995). Oral bioavailability of CHF1194, an inclusion complex of piroxicam and ?-cyclodextrin, in healthy subjects under single dose and steady-state conditions. European Journal of Clinical Pharmacology. 47(6). 531–6. 18 indexed citations
8.
Lebacq, E., et al.. (1994). Exploratory study of the decongestive effect of Rhinopront syrup in adults and in children with acute rhinitis.. PubMed. 29(2-3). 113–24. 2 indexed citations
9.
Stockis, Armel, Franco Borzio, Flavio Gaspari, et al.. (1993). Pharmacokinetics of Brodimoprim in Special Populations. Journal of Chemotherapy. 5(6). 480–487. 3 indexed citations
10.
Stockis, Armel, et al.. (1992). Relative bioavailability of carbinoxamine and phenylpropanolamine from a retard suspension after single dose administration in healthy subjects.. PubMed. 42(12). 1478–81. 1 indexed citations
11.
Acerbi, Daniela, E. Lebacq, Ivano Rondelli, Armel Stockis, & Paolo Ventura. (1990). Rapid Oral Absorption Profile of Piroxicam from its β-Cyclodextrin Complex. Clinical Drug Investigation. 2(S4). 50–55. 10 indexed citations
12.
Lebacq, E.. (1971). LIVER DISEASE IN CARRIERS OF Au ANTIGEN. The Lancet. 298(7731). 977–978. 5 indexed citations
13.
Arala‐Chaves, Mário, E. Lebacq, & J.F. Heremans. (1967). Fractionation of Human Leukocyte Extracts Transferring Delayed Hypersensitivity to Tuberculin. International Archives of Allergy and Immunology. 31(4). 353–365. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriele Buttinelli Breakdown of academic impact, for papers by Annalisa Grandin Breakdown of academic impact, for papers by Robert E. Levitz Breakdown of academic impact, for papers by Monjori Mitra Breakdown of academic impact, for papers by I. Rebière Breakdown of academic impact, for papers by R.E. Tettmar Breakdown of academic impact, for papers by Chang-Phone Fung Breakdown of academic impact, for papers by Joo-Shil Lee Breakdown of academic impact, for papers by Birgitte Korsager Breakdown of academic impact, for papers by P Joseph
Rankless by CCL
2026